Cargando…
Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
BACKGROUND: Cancer and its treatment lead to increased financial distress for patients. To the authors' knowledge, to date, no standardized patient‐reported outcome measure has been validated to assess this distress. METHODS: Patients with AJCC Stage IV solid tumors receiving chemotherapy for a...
Autores principales: | de Souza, Jonas A., Yap, Bonnie J., Wroblewski, Kristen, Blinder, Victoria, Araújo, Fabiana S., Hlubocky, Fay J., Nicholas, Lauren H., O'Connor, Jeremy M., Brockstein, Bruce, Ratain, Mark J., Daugherty, Christopher K., Cella, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298039/ https://www.ncbi.nlm.nih.gov/pubmed/27716900 http://dx.doi.org/10.1002/cncr.30369 |
Ejemplares similares
-
Financial Toxicity
por: Nogueira, Luciana de Alcantara, et al.
Publicado: (2020) -
Financial toxicity in lung cancer
por: Boulanger, Mary, et al.
Publicado: (2022) -
Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer
por: Honda, Kazunori, et al.
Publicado: (2019) -
Value and Financial Toxicity of New Cancer Drugs
por: Wickham, Rita J.
Publicado: (2016) -
Financial Toxicity of Having Bladder Cancer
por: Messing, Edward M.
Publicado: (2018)